GRIN3A defines an immunosuppressive niche in advanced prostate cancer

Key Points

• GRIN3A provides an immunosuppressive environment, affecting cancer progression and treatment response.
• Advanced prostate cancer shows a significant correlation with elevated GRIN3A levels in tumor samples.
• Observational analysis across multiple cancer cases indicates GRIN3A as a vital contributor to immune evasion.
• These findings suggest targeting GRIN3A might enhance cancer immunotherapy efficacy, warranting further investigation.